Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Oct 16, 2020 3:43pm
97 Views
Post# 31730080

RE:Price

RE:PriceYou realize that the two big SH own 85% of the company that they apparently paid $11.53USD.

Why would they sell?

Steve33 wrote:
With this share price and small float I'm surprised a big pharma doesn't try to buy this company. What a steal that would be. Especially when there so close to their first approved drug. Anyhow I'm shocked that the support is not there. We could be looking at a forty to fifty dollar stock in the near future. I'm guessing most people don't understand the high probability this has to getting passed.


<< Previous
Bullboard Posts
Next >>